Gnak

Gnak is an intravenous electrolyte solution that contains magnesium chloride hexahydrate, potassium chloride, sodium chloride, glucose, and sodium acetate trihydrate. It is supplied as a sterile solution for parenteral infusion and is intended for fluid and electrolyte replacement in clinical settings across the EU. The formulation provides essential electrolytes and carbohydrate energy directly into the bloodstream.

Gnak is prescribed for patients who require rapid restoration of fluid volume and electrolyte balance. It is commonly used in hospital and emergency environments where intravenous therapy is indicated.

- Replacement of fluids in hypovolemia or dehydration - Correction of electrolyte deficiencies such as hypokalemia or hypomagnesemia - Support during surgical procedures requiring fluid management - Management of metabolic disturbances associated with low glucose - Adjunct therapy for patients receiving parenteral nutrition

Side effects of Gnak may vary in frequency and severity. Patients should be monitored for any adverse reactions during and after infusion.

Common: - Mild infusion site irritation or erythema - Transient nausea or vomiting - Temporary increase in serum sodium levels - Mild headache or dizziness

Serious: - Severe hyperkalemia leading to cardiac arrhythmia - Acute hypermagnesemia causing respiratory depression - Anaphylactic reaction with hypotension and bronchospasm - Significant electrolyte imbalance requiring medical intervention

Gnak should be administered with careful assessment of the patient's clinical status and laboratory values. Specific considerations help minimize risks.

- Verify electrolyte levels and renal function before initiation - Adjust infusion rate in patients with cardiac or renal disease - Use caution in patients with known hypersensitivity to any component - Monitor vital signs and serum electrolytes during therapy - Avoid rapid infusion in pediatric or frail patients - Discontinue if signs of severe electrolyte disturbance appear

Gnak may interact with other medications that affect electrolyte balance or cardiovascular function. Awareness of these interactions can guide safe co‑administration.

Avoid: - Concurrent use of potassium‑sparing diuretics that may cause hyperkalemia - High‑dose magnesium supplements that could lead to hypermagnesemia - Intravenous sodium bicarbonate solutions that may exacerbate sodium overload

Use with caution: - Loop diuretics that alter potassium and magnesium excretion - ACE inhibitors or ARBs that affect renal electrolyte handling - Calcium channel blockers that can influence cardiac conduction in the presence of electrolyte shifts